Home › Mallinckrodt buying Cadence Pharmaceuticals for approximately $1.21 billion
 

Keywords :   


Mallinckrodt buying Cadence Pharmaceuticals for approximately $1.21 billion

2014-02-11 17:48:35| Biotech - Topix.net

The health care products company Mallinckrodt is buying Cadence Pharmaceuticals for about $1.21 billion in a bid to strengthen its specialty drugs unit.

Tags: approximately buying billion pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.05SONGWON Announces 1Q 2024 Financial Results
14.05Tesco chief's pay more than doubles to 10m
14.05Evonik Receives the Trade Excellence Award in Alabama
14.05My emails look ludicrous, says ex-Post Office PR boss
14.05Polyart to market full range of services under PolyServices brand
14.05Nilpeter partners with B&R for advanced vision system
14.05Beontag enters wine label market in Latin America
14.05UPM Raflatac receives industry first from RecyClass
More »